Recent Quarter Total Invested
$3.69 B
Recent Quarter Institutional Ownership Percentage
114.08%
Total Invested of Last Quarter
$3.76 B
Ownership Percentage of Last Quarter
111.23%
Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 305,169 | $13.67 M | -14.55% | 0.42% |
| DUQUESNE FAMILY OFFICE LLC | 08/14/2024 | 309,000 | $13.84 M | 0.00% | 0.43% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 315,220 | $14.12 M | 30.60% | 0.44% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 350,766 | $15.71 M | -44.34% | 0.49% |
| FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 369,302 | $16.54 M | 100.00% | 0.51% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 377,663 | $16.92 M | -2.68% | 0.52% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 386,450 | $17.31 M | 30.35% | 0.53% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 390,941 | $17.51 M | 312.09% | 0.54% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 400,000 | $17.92 M | 23.08% | 0.55% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 410,342 | $18.38 M | 100.00% | 0.57% |
| FISHER ASSET MANAGEMENT, LLC | 08/14/2024 | 444,670 | $19.92 M | 1.98% | 0.62% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 462,766 | $20.73 M | -16.43% | 0.64% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 479,681 | $21.48 M | -27.34% | 0.66% |
| FIERA CAPITAL CORP | 08/19/2024 | 480,409 | $21.52 M | 1.03% | 0.66% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 497,000 | $22.26 M | 9,840.00% | 0.69% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 515,000 | $23.07 M | 9.57% | 0.71% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 546,234 | $24.47 M | 0.65% | 0.76% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 546,759 | $24.49 M | -14.68% | 0.76% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 551,095 | $24.68 M | -11.08% | 0.76% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 557,184 | $24.96 M | 15.94% | 0.77% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 588,818 | $26.37 M | -8.53% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 597,049 | $26.74 M | 24.77% | 0.83% |
| NORTHERN TRUST CORP | 08/14/2024 | 606,037 | $27.14 M | 0.77% | 0.84% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 616,227 | $27.60 M | -0.85% | 0.85% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 649,190 | $29.08 M | -24.87% | 0.90% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 653,557 | $29.27 M | 383.07% | 0.90% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 735,088 | $32.92 M | -30.63% | 1.02% |
| MORGAN STANLEY | 08/14/2024 | 838,625 | $37.56 M | 36.99% | 1.16% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 861,422 | $38.58 M | 108.47% | 1.19% |
| LORD, ABBETT & CO. LLC | 08/14/2024 | 887,921 | $39.77 M | -7.95% | 1.23% |
| NOVO HOLDINGS A/S | 08/20/2024 | 1.00 M | $44.79 M | -8.98% | 1.38% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.07 M | $47.75 M | -23.33% | 1.47% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2024 | 1.20 M | $53.77 M | -28.97% | 1.66% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.28 M | $57.37 M | -7.52% | 1.77% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.35 M | $60.34 M | -49.25% | 1.86% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.35 M | $60.47 M | 17.39% | 1.87% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.48 M | $66.12 M | 0.00% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.68 M | $75.19 M | 19.76% | 2.32% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 2.46 M | $109.97 M | 24.14% | 3.40% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 2.51 M | $112.57 M | -19.57% | 3.48% |
| JENNISON ASSOCIATES LLC | 08/05/2024 | 2.78 M | $124.52 M | -1.34% | 3.85% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 2.78 M | $124.55 M | -43.82% | 3.85% |
| STATE STREET CORP | 08/14/2024 | 2.81 M | $125.99 M | -13.59% | 3.89% |
| FMR LLC | 08/13/2024 | 4.10 M | $183.50 M | -8.22% | 5.67% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 4.16 M | $186.12 M | 0.00% | 5.75% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 4.41 M | $197.37 M | 15.26% | 6.10% |
| VANGUARD GROUP INC | 08/13/2024 | 4.51 M | $202.20 M | 26.28% | 6.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 4.62 M | $206.95 M | 55.49% | 6.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 6.11 M | $273.76 M | 16.95% | 8.46% |
| BLACKROCK INC. | 08/13/2024 | 6.23 M | $279.06 M | 14.61% | 8.62% |
Crinetics Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRNX shares?
During the previous two years, 266 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 6.23 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 6.11 M
WELLINGTON MANAGEMENT GROUP LLP: 4.62 M
VANGUARD GROUP INC: 4.51 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.41 M
EcoR1 Capital, LLC: 4.16 M
-
What percentage of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors?
114.08% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CRNX ?
Institutional investors have bought a total of 83.12 M shares in the last 24 months. This purchase volume represents approximately $4.42 B in transactions.